Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › Lemonade Inc. (LMND) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Insurance - Property & Casualty
$30.92
+0.01 (0.03%)10 Quality Stocks Worth Considering Now
Researching Lemonade (LMND) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on LMND and similar high-potential opportunities.
Based on our analysis of 15 Wall Street analysts, LMND has a neutral consensus with a median price target of $25.00 (ranging from $15.00 to $60.00). The overall analyst rating is Hold (4.9/10). Currently trading at $30.92, the median forecast implies a -19.1% downside. This outlook is supported by 1 Buy, 4 Hold, and 4 Sell ratings.
The most optimistic forecast comes from Andrew Boone at Citizens Capital Markets, projecting a 94.0% upside. Conversely, the most conservative target is provided by Michael Zaremski at BMO Capital, suggesting a 51.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for LMND.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Apr 22, 2025 | Keefe, Bruyette & Woods | Thomas McJoynt-Griffith | Underperform | Maintains | $22.00 |
Apr 8, 2025 | Morgan Stanley | Bob Huang | Underweight | Downgrade | $24.00 |
Feb 27, 2025 | Piper Sandler | Neutral | Maintains | $0.00 | |
Feb 26, 2025 | Citizens Capital Markets | Andrew Boone | Market Outperform | Reiterates | $60.00 |
Feb 26, 2025 | Piper Sandler | Arvind Ramnani | Neutral | Maintains | $34.00 |
Nov 22, 2024 | JMP Securities | Ronald Josey | Market Outperform | Maintains | $60.00 |
Nov 21, 2024 | Piper Sandler | Arvind Ramnani | Neutral | Maintains | $44.00 |
Nov 21, 2024 | BMO Capital | Michael Zaremski | Underperform | Maintains | $15.00 |
Nov 20, 2024 | Morgan Stanley | Michael Phillips | Equal-Weight | Upgrade | $42.00 |
Nov 15, 2024 | Morgan Stanley | Michael Phillips | Underweight | Maintains | $23.00 |
Nov 7, 2024 | Keefe, Bruyette & Woods | Thomas McJoynt-Griffith | Underperform | Downgrade | $21.00 |
Nov 1, 2024 | Piper Sandler | Arvind Ramnani | Neutral | Maintains | $25.00 |
Oct 15, 2024 | JMP Securities | Karol Chmiel | Market Outperform | Reiterates | $40.00 |
Oct 9, 2024 | Jefferies | Yaron Kinar | Underperform | Maintains | $14.00 |
May 7, 2024 | Jefferies | Yaron Kinar | Underperform | Maintains | $16.00 |
May 2, 2024 | Piper Sandler | Arvind Ramnani | Neutral | Maintains | $18.00 |
Apr 15, 2024 | JMP Securities | Karol Chmiel | Market Outperform | Reiterates | $40.00 |
Mar 4, 2024 | Keefe, Bruyette & Woods | Thomas McJoynt-Griffith | Market Perform | Maintains | $18.00 |
Feb 29, 2024 | Piper Sandler | Arvind Ramnani | Neutral | Reiterates | $17.00 |
Feb 28, 2024 | Morgan Stanley | Michael Phillips | Underweight | Maintains | $14.00 |
The following stocks are similar to Lemonade based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Lemonade Inc. has a market capitalization of $2.19B with a P/E ratio of 0.0x. The company generates $558.60M in trailing twelve-month revenue with a -38.9% profit margin.
Revenue growth is +27.0% quarter-over-quarter, while maintaining an operating margin of -38.4% and return on equity of -35.6%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Offers technology-driven property and casualty insurance.
The company operates a digital platform that provides renters, homeowners, pet, and term life insurance. By utilizing artificial intelligence and behavioral economics, Lemonade simplifies the insurance process, ensuring quick and transparent service. It generates revenue through insurance premiums while also engaging customers with a unique giveback program for leftover funds.
Lemonade targets urban, tech-savvy markets, appealing particularly to younger consumers who prefer digital solutions and corporate social responsibility. Its innovative approach positions it as a significant player in the insurtech sector.
Financial Services
Insurance - Property & Casualty
1,235
Mr. Daniel Asher Schreiber
United States
2020
PLMR is positioning itself as a key player in the crop insurance sector, with its growing emphasis on Surety signaling strong prospects for future expansion.
A mid-cap company is leveraging AI and machine learning to disrupt a traditional industry, presenting potential for significant investor returns amid the tech giants' dominance.
The mid-cap innovator leveraging AI in a traditional industry could disrupt the market, presenting significant growth opportunities and potential high returns for investors.
The saying "sell in May and go away" suggests that the S&P 500 historically yields weaker returns from May to October than from November to April.
The "sell in May" adage suggests a seasonal trend in stock performance, indicating potential underperformance in summer months, which could influence investment strategies and timing.
Investors are encouraged to consider small-cap stock Lemonade, which has shown consistent premium growth and stable loss ratios, aiming for adjusted EBITDA breakeven by FY26.
Lemonade's consistent premium growth and steady loss ratios amid challenges highlight its resilience. AI-driven efficiency could lead to profitability, making it a compelling small-cap investment opportunity.
Lemonade (LMND) has released its fiscal 2025 first-quarter financial report, providing insights into its performance for investors.
Lemonade's fiscal 2025 Q1 report provides insights into its financial health and growth trajectory, impacting investor sentiment and potential stock performance.
The company reported Q1 results affirming its outlook and plans to achieve EBITDA break-even by the end of 2026.
Positive Q1 results and a clear path to profitability signal potential for future growth, which can influence stock performance and investor confidence.
Lemonade, Inc. (NYSE: LMND) will host its Q1 2025 earnings conference call on May 6, 2025, at 8:00 AM ET with key executives participating.
Lemonade's Q1 2025 earnings call will reveal financial performance and strategic insights, influencing investor sentiment and stock price movements.
Based on our analysis of 15 Wall Street analysts, Lemonade Inc. (LMND) has a median price target of $25.00. The highest price target is $60.00 and the lowest is $15.00.
According to current analyst ratings, LMND has 1 Buy ratings, 4 Hold ratings, and 4 Sell ratings. The stock is currently trading at $30.92. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict LMND stock could reach $25.00 in the next 12 months. This represents a -19.1% decrease from the current price of $30.92. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates a digital platform that provides renters, homeowners, pet, and term life insurance. By utilizing artificial intelligence and behavioral economics, Lemonade simplifies the insurance process, ensuring quick and transparent service. It generates revenue through insurance premiums while also engaging customers with a unique giveback program for leftover funds.
The highest price target for LMND is $60.00 from Andrew Boone at Citizens Capital Markets, which represents a 94.0% increase from the current price of $30.92.
The lowest price target for LMND is $15.00 from Michael Zaremski at BMO Capital, which represents a -51.5% decrease from the current price of $30.92.
The overall analyst consensus for LMND is neutral. Out of 15 Wall Street analysts, 1 rate it as Buy, 4 as Hold, and 4 as Sell, with a median price target of $25.00.
Stock price projections, including those for Lemonade Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.